story of the week
Everolimus-Eluting Stents Noninferior to CABG in Outcomes at 3 Years
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease
N. Engl. J. Med 2016 Oct 31;[EPub Ahead of Print], GW Stone, JF Sabik, PW Serruys, CA Simonton, P Généreux, J Puskas, DE Kandzari, MC Morice, N Lembo, WM Brown, DP Taggart, A Banning, B Merkely, F Horkay, PW Boonstra, AJ van Boven, I Ungi, G Bogáts, S Mansour, N Noiseux, M Sabaté, J Pomar, M Hickey, A Gershlick, P Buszman, A Bochenek, E Schampaert, P Pagé, O Dressler, I Kosmidou, R Mehran, SJ Pocock, AP KappeteinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.